|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
In patients dying from asthma, extensive mucous plugging occurs in the airways, associated with
goblet cell hyperplasia. In this study, we examined the hypothesis that platelet-activating factor
(PAF) induces goblet cell hyperplasia and mucin gene expression. After instilling PAF into the airways
of guinea pigs and rats, we stained airway goblet cells with Alcian blue/periodic acid-Schiff and determined the number of goblet cells and percentage of stained area within the epithelium. In guinea
pigs, one instillation of PAF (10
5 M, 100 µl) increased the goblet cell-stained area time-dependently, beginning at 24 h, maximum at 72 h. PAF also caused tracheal recruitment of eosinophils by 24 h,
maximum at 48 h. In rats, which have few goblet cells in airways, PAF (3 instillations, 10
5 M, 200 µl)
caused striking goblet cell hyperplasia, greatest in peripheral airways. Tumor necrosis factor alpha
(TNF
) alone had no significant effect on goblet cells, but together with PAF, it caused exaggerated
goblet cell hyperplasia. In rat tracheas studied by in situ hybridization, PAF induced mucin MUC5
gene expression in epithelial cells that stained for mucosubstances. In summary, PAF induces goblet
cell hyperplasia and TNF
potentiates this effect.
| |
INTRODUCTION |
|---|
|
|
|---|
Platelet-activating factor (PAF), a phospholipid produced by activated platelets, leukocytes, and endothelial cells, is a potent proinflammatory autacoid with diverse physiological and pathological effects, including activation of neutrophils and eosinophils, bronchoconstriction, plasma protein extravasation, and goblet cell secretion (1). Because of these potent actions, it has been suggested that PAF could play a role in the pathogenesis of asthma. In support of this possibility, an increase in circulating PAF has been reported in asthmatic patients, especially during acute attacks (4, 5). In addition, in 5% of the Japanese population, severe asthma is positively correlated with a deficiency of PAF acetylhydrolase (6), the enzyme that degrades PAF into the inactive form, lyso-PAF. Furthermore, patients with mild asthma are reported to have reduced PAF acetylhydrolase activity in bronchoalveolar lavage fluid (7).
Mucus secretion may play an important role in airway obstruction in severe asthma. Postmortem studies of patients who died of asthma showed extensive obstruction of airways by mucous plugs (8). Furthermore, in a mouse model of allergic asthma, local delivery of antigen resulted in peripheral airway plugging with mucus (13, 14), emphasizing the potential importance of goblet cell degranulation in asthmatic responses.
PAF is known to cause mucus secretion in rat nasal airways
(3), but it is unknown whether PAF causes goblet cell hyperplasia. In the present study, we examined the hypothesis that
PAF stimulates goblet cell growth in airway epithelium. Tumor necrosis factor alpha (TNF
) is a proinflammatory cytokine. High levels of TNF
have been detected in bronchoalveolar lavage fluid from asthmatics (15), and TNF
inhibits PAF
acetylhydrolase, the enzyme responsible for PAF breakdown
(16). Therefore, we also hypothesized that TNF
could potentiate the goblet cell hyperplasia induced by PAF.
Studies were performed in guinea pigs. Because guinea
pigs have goblet cells in the control state, we also studied
pathogen-free rats, which normally have few goblet cells in the
airways. We examined the effect of PAF plus TNF
on goblet
cell morphology in two ways: (1) we stained mucosubstances
in the airways with Alcian blue/PAS and evaluated the areas
of positive staining morphometrically; (2) we examined the
gene expression of mucin MUC5 in the airways, because mucin MUC5 gene is known to be expressed in rodent airway epithelial cells (17).
| |
METHODS |
|---|
|
|
|---|
Animals and Maintenance
Pathogen-free male Dunkin-Hartley guinea pigs (350 to 450 g body weight; Simonsen Co., Gilroy, CA) and male F344 Fisher rats (230 to 250 g body weight; Simonsen Co.) were used in this study. Guinea pigs were housed one per polycarbonate cage and rats three per cage. The animals were supplied with sterilized hardwood chip bedding and filter tops. Animal rooms were maintained at 20-22° C with a relative humidity of 20 to 50% and a 12-h light-dark cycle starting at 6:00 A.M. Food and water were provided ad libitum.
Drugs
Drugs from the following U.S. sources were used: L-
-phosphatidylcholine,
-acetyl-
-o-alkyl (1-O-Alkyl-2-acetyl-sn-glycero-3-phosphocholine; PAF) (Sigma, St. Louis, MO), TNF
(Sigma), ketamine hydrochloride (Ketalar; Parke-Davis, Div. of Warner-Lambert Co., Morris
Plains, NJ), methohexital sodium (Brevital Sodium; Eli Lilly & Co., Indianapolis, IN), acepromazine maleate (PromAce; Fort Dodge Laboratories, Inc., Fort Dodge, IA), and NPC 15669 (Scios Inc., Mountain
View, CA). PAF was dissolved in 100% ethanol and freshly diluted in
sterile phosphate-buffered saline (PBS) before experiments. The final concentration of ethanol in the diluent is 0.01%. PBS with 0.01% ethanol was used as a vehicle in control groups.
Studies in Guinea Pigs and Rats
Studies were first performed in guinea pigs and showed that PAF caused goblet cell hyperplasia. Because guinea pig airways contain goblet cells and eosinophils in the control state, we also studied pathogen-free rats, a species that normally has few goblet cells or eosinophils in the airways.
Pathogen-free male Dunkin-Hartley guinea pigs were anesthetized with ketamine (60 mg/kg, intramuscularly) and acepromazine maleate (0.5 mg/kg, intramuscularly) and were allowed to breathe spontaneously. PAF (10
5 M, 100 µl) or vehicle (PBS, 100 µl) was instilled intratracheally via a 22-gauge Angiocath catheter (Becton Dickinson, Sandy, UT) through the mouth, while the laryngeal area was visualized using a high-intensity illuminator (FiberLite; Dolan Jenner
Industries, Inc., Lawrence, MA). Guinea pigs were euthanized 6, 24, 48, or 72 h after PAF instillation. To study the effect of the leumedin NPC 15669 (a drug that prevents leukocyte migration) on PAF-induced responses, a group of guinea pigs (n = 4) were pretreated with NPC 15669 (100 mg/kg, intraperitoneally) 2 h before PAF was instilled intratracheally (10
5 M, 100 µl) and again 24 h later with a second dose. The animals were euthanized 48 h after PAF instillation.
Pathogen-free male F344 Fisher rats were anesthetized with methohexital sodium (Brevital, 25 mg/kg, intraperitoneally) and allowed to
breathe spontaneously. PAF (10
5 M) in vehicle (200 µl), PAF (10
5 M)
plus TNF
(1 µg/ml) in vehicle (200 µl), or vehicle alone (200 µl) was
instilled intratracheally via the mouth, similarly to the guinea pigs. In
eight rats, PAF (10
5 M) or vehicle was instilled once, and the rats
were euthanized 24 h later. In another eight rats, PAF (10
5 M) or vehicle was instilled twice with 48-h intervals, and the rats were euthanized 48 h later. In the remaining rats, PAF (10
5 M) alone, TNF
alone, PAF plus TNF
(1 µg/ml), or vehicle was instilled three times
with 48-h intervals, and the animals were killed 48 h after the last instillation.
Tissue Preparation
After various times of exposure, the guinea pigs and rats were anesthetized deeply with sodium pentobarbital (65 mg/kg, intraperitoneally), the heart was exposed, a blunt-ended needle was inserted from the apex of the left ventricle into the aorta, and the systemic circulation was perfused with 1% paraformaldehyde in PBS. The lungs were fixed by perfusion via airways at 5 to 6 cm H2O pressure and also via the pulmonary artery. The trachea and lungs were removed and fixed with 4% paraformaldehyde for 24 h. After fixation, the guinea pig tracheal segments, beginning 5 mm below the larynx and 14 mm long, were cut across, and then cut longitudinally along the membranous portion into two pieces. In rats, cross sections of trachea were used because of the smaller size of the trachea; two segments, beginning 5 mm below the larynx, and 4 to 5 mm long were cut from each trachea. The right main stem bronchus was dissected and cut as cross sections. The right caudal lobe was used to study the intrapulmonary bronchi (eighth or ninth generation; see Reference 18).
The tissues from guinea pigs and rats were dehydrated with graded concentrations of ethanol (50%, 70%, 85%, 95%, 100%) and embedded in methacrylate JB-4 (Polysciences, Inc., Warrington, PA). Then the tissues were sectioned (4 µm in thickness), stained with Alcian blue and periodic acid-Schiff (PAS) for acidic and neutral intracellular mucins and counterstained with hematoxylin. In separate sections, Luna's stain was used to detect eosinophils (3), which contained red granules and blue bilobate nuclei. Slides were observed at ×400 magnification, using an Axioplan microscope (Zeiss Inc., Thornwood, NY) equipped with a Plan-NEOFLUAR ×40/0.75 objective lens. Eosinophil numbers were counted in 20 consecutive high-power fields (HPF, ×400 magnification) of the epithelial layer (basement membrane to cell apices).
Morphometric Analysis of Intraepithelial Mucosubstances
The percentage of Alcian blue/PAS-stained mucosubstance area in the epithelium was determined using a semi-automatic image analysis system. The stained slides were examined with a light microscope (Axioplan; Zeiss) that was connected to a video camera (3CCD; Sony Corp. of America, Park Ridge, NJ) and a control unit (DXC7550MD; Sony Corp.), and then a color digital image capture board (IMAXX; PDI, Redmond, WA) and a color monitor (Multisync XV17; NEC Corp., Tokyo, Japan). Images of the airway epithelium were recorded from 10 consecutive high-power fields with a phase contrast lens at ×400. Analysis was performed on a Power Macintosh 9500/120 computer (Apple Computer, Inc., Cupertino, CA) with images displayed on the color monitor, using the public domain NIH Image program (developed at the U.S. National Institutes of Health and available from the Internet by anonymous FTP from or on floppy disk from the National Technical Information Service, Springfield, Virginia; part number PB95-500195GEI). The area of epithelium and Alcian blue/PAS-stained mucosubstances within the epithelium were manually circumscribed and analyzed using the NIH Image program. The data are expressed as the percentage of the total area of epithelium occupied by Alcian blue/PAS stain.
Counting of Goblet Cells and Pregoblet Cells
We counted goblet cells and total epithelial cells (total number of nuclei) from 10 captured images (see above section) in guinea pig tracheal epithelium. The linear length of the basal lamina under each analyzed region of epithelium was determined by tracing the contour of the digitized image of the basal lamina, using the NIH image program. The data are expressed as number of cells per mm basal lamina. In rats, especially after one or two instillations of PAF, a number of "developing" goblet cells are formed. These cells show Alcian blue/PAS-positive staining, the granules are small, and the cells are not packed with granules. We call these developing goblet cells "pregoblet" cells, a stage before these cells become complete goblet cells (cells packed with granules). Therefore, we counted goblet cells, pregoblet cells, and total epithelial cells (which also include ciliated cells, nonciliated secretory cells, and basal cells). Goblet cells are tall, cuboidal, goblet to low columnar in shape, with abundant Alcian blue/PAS-stained granules filling most of the cytoplasm between the nucleus and the luminal surface. Pregoblet cells are defined as cells with smaller mucus-stained areas (< 1/3 height in epithelium from basement membrane to luminal surface) or with sparsely and lightly Alcian blue/PAS-stained, small granules.
Probe Preparation
The complementary DNA (cDNA) for rat MUC5 was generously
provided by Dr. Carol Basbaum. A 320-bp cDNA fragment of rat
MUC5 was subcloned into the Xba/HindIII site of the transcription
vector, pBluescript-SK(
) (Stratagene, La Jolla, CA). To prepare
RNA probes for in situ hybridization, this recombinant plasmid containing the rat MUC5 cDNA fragment was linearized and transcribed
in vitro with the T7 or T3 polymerase to obtain antisense or sense probe, respectively. The probes for in situ hybridization were generated in the
presence of sulfer-35-uridine triphosphate ([35S]UTP). After transcription, the cDNA template was digested with deoxyribonuclease (DNase),
and the radiolabeled RNA was purified via a Sephadex G-25 Quick
Spin Column (Boehringer Mannheim, Indianapolis, IN) and precipitated
in an ethanol/ammonium acetate solution. Before use, RNA probes were
washed with 70% ethanol and diluted in 10 mM DTT.
In Situ Hybridization
Airway tissues from rats were fixed with 4% paraformaldehyde for 1 h and washed in PBS. The tissues were cryoprotected with 30% sucrose overnight and then embedded in optimal cutting temperature (OCT) compound (Sakura Finetek U.S.A., Inc., Torrance, CA) and frozen. Frozen sections (5 µm) were cut and placed on positively charged glass slides (Superfrost Plus; Fisher Scientific, Pittsburgh, PA). Sections cut in close proximity were used for hybridization with sense and antisense probes. Alternate sections were used for Alcian blue/PAS staining.
The specimens were refixed in 4% paraformaldehyde, rehydrated
in 0.5× standard saline citrate (SSC), and then acetylated in triethanolamine with acetic anhydride. Hybridization was carried out with
2,500 to 3,000 cpm/µl of antisense or sense probe in 50% deionized
formamide, 0.3 M NaCl, 20 mM Tris, 5 mM EDTA, 1× Denhardt's
solution, 20 mM dithiothreitol, 10% dextran sulfate, 0.5 mg/ml yeast
transfer ribonucleic acid (tRNA), and 0.5 mg/ml sonicated salmon
sperm DNA at 55° C overnight. Posthybridization treatment consisted
of washes with 2× SSC, 1 mM EDTA, 10 mM
-mercaptoethanol at
room temperature, incubation with ribonuclease (RNase) solution (20 µg/ml) for 30 min at room temperature, and further washes in 0.1×
SSC, 1 mM EDTA, 10 mM
-mercaptoethanol at 55° C for 2 h and
then in 0.5× SSC at room temperature. Specimens were dehydrated, air-dried, and covered with Kodak NBT nuclear track emulsion (Eastman Kodak, Rochester, NY) for autoradiography. After exposure for 7 to 21 d at 4° C, the slides were developed, fixed, and counterstained with hematoxylin.
Statistical Evaluation
All data are expressed as means ± SEM. For statistical analysis, the two-way or one-way analysis of variance (ANOVA) followed by Dunnett t test, or linear regression test or Student t test was used as appropriate. A probability of less than 0.05 was considered a statistically significant difference.
| |
RESULTS |
|---|
|
|
|---|
PAF-induced Goblet Cell Hyperplasia: Guinea Pig Trachea
In the naive state (untreated animals), the tracheal epithelium
of guinea pigs contained goblet cells (Table 1); vehicle-treated control guinea pigs showed no change in the number of goblet
cells, total epithelial cells, or the percentage of area of epithelium stained with Alcian blue/PAS for up to 72 h (p > 0.05;
Table 1 and Figure 1, upper panel, open bars). After a single
intratracheal instillation of PAF (10
5 M, 100 µl; Figure 1, upper panel, solid bars), there was a significant increase in number of goblet cells and mucus-stained area, detectable as early
as 24 h after instillation (Table 1; Figure 1, upper panel). After
exposure to PAF, there was a time-dependent increase in mucous area (linear regression, r = 0.6, p < 0.05, n = 17), which
appeared to reach a plateau at 72 h after instillation. The number of total epithelial cells per mm basal lamina 72 h after
PAF instillation was slightly but not statistically significantly increased (p > 0.05, Table 1).
|
|
In control guinea pigs, a significant number of eosinophils
was present in the airway epithelium, and the number of eosinophils did not increase after exposure to vehicle up to 72 h (p > 0.05, Figure 1, lower panel ). However, instillation of PAF
(10
5 M, 100 µl) caused a further time-dependent eosinophil
recruitment into the airway epithelium (Figure 1, lower panel;
linear regression, r = 0.84, p < 0.0001, n = 17). Maximal eosinophil recruitment occurred at 48 h. Figure 2 shows typical light
micrographs of goblet cells and eosinophils in the airways in
response to PAF.
|
Because PAF caused both goblet cell hyperplasia and eosinophil recruitment, we studied the effect of pretreatment of guinea pigs with NPC 15669, a leumedin that inhibits leukocyte recruitment (19). NPC 15669 prevented the recruitment of eosinophils into the airways (p < 0.001), but had no effect on PAF-induced goblet cell hyperplasia (p > 0.05, Figure 3). After NPC 15669 treatment, the number of goblet cells (59 ± 9 per mm basal lamina) was not statistically different (p > 0.05) from that (61 ± 11 per mm basal lamina) in the animals given PAF alone.
|
PAF-induced Goblet Cell Hyperplasia in Rat Airways
Because the airways of control guinea pigs contain goblet cells,
we also studied pathogen-free rats, a species whose airways normally contain few goblet cells (Table 2), especially in the trachea (Figures 4 and 5) and few eosinophils (0-1 per 10 mm
epithelium; data not shown). In tracheal epithelium, after one
or two instillations of PAF (10
5 M, 200 µl, n = 4), instillation
of PAF resulted in mostly pregoblet cells but also increased
the number of goblet cells (Table 2). When PAF (10
5 M, 200 µl,
n = 4) was instilled three times with 48-h intervals, more mature goblet cells were found (Table 2). The number of total
epithelial cells was slightly but not statistically significantly increased (Table 2). In main stem bronchial epithelium, PAF instilled three times increased the number of goblet cells from
11 ± 2 to 44 ± 7 per mm basal lamina (p < 0.01) and the number of total epithelial cells from 168 ± 9 to 206 ± 12 per mm
basal lamina (p < 0.05), while the number of pregoblet cells
was not changed (from 17 ± 1 to 18 ± 2 per mm basal lamina,
p > 0.05). In intrapulmonary bronchial epithelium, PAF instilled three times increased the number of goblet cells from 7 ± 3 to 63 ± 8 per mm basal lamina (p < 0.001) and the number
of total epithelial cells from 170 ± 2 to 203 ± 10 per mm basal
lamina (p < 0.05), while the number of pregoblet cells was not
changed (from 21 ± 2 to 24 ± 23 per mm basal lamina, p > 0.05). PAF also increased the Alcian blue/PAS-stained mucous area; the percentage of stained area in intrapulmonary bronchi was greater than in the trachea (p < 0.01, Figure 4). Figure 5 shows typical light micrographs of goblet cells at the three anatomic levels in response to PAF. PAF did not recruit significant numbers of eosinophils or neutrophils in rats (p > 0.05, data not shown).
|
|
|
Effect of TNF
on PAF-induced Goblet Cell
Hyperplasia in Rat Trachea
PAF (10
5 M, 200 µl) given three times with 48-h intervals
caused significant goblet cell hyperplasia and increased the
mucous staining area in rat trachea (p < 0.01). TNF
(1 µg/ml,
200 µl) alone caused no significant increase in the number of
goblet cells or in the percentage of mucous area (Table 2 and
Figure 6, p > 0.05). However, when PAF and TNF
were administered together, a marked increase in number of goblet
cells and percentage of mucous area occurred (Table 2 and
Figure 6, p < 0.001); the effect was considerably greater than
that caused by PAF alone (p < 0.01) (Table 2 and Figure 6).
PAF plus TNF
increased the number of total epithelial cells
(p < 0.001), an effect that was greater than PAF alone (p < 0.01) (Table 2).
|
PAF-induced MUC5 Gene Expression in Rat Airways
In control rats and in vehicle-treated rats, no signals were detected with the antisense probe of MUC5 in the trachea (n = 4, Figures 7f and 7g). When PAF (10
5 M, 200 µl) was instilled
into the trachea once and the rats were euthanized 24 h later,
only low levels of expression were detected and only in 2 to 3 epithelial cells per cross section (n = 3, data not shown). However, when PAF (10
5 M, 200 µl) was instilled three times at
48-h intervals and the animals were euthanized 48 h after the
last instillation, more intense expression of MUC5 occurred in
the tracheal epithelium (n = 4, Figures 7b and 7c); MUC5 expression was found in cells that stained for mucins (in subsequent sections, Figure 7a). TNF
alone did not induce MUC5
expression (data not shown). Sections examined with the
MUC5 sense probe showed no expression (Figures 7d and 7e).
Signals in other cell types, including smooth muscle and connective tissue, were not detectable.
|
| |
DISCUSSION |
|---|
|
|
|---|
This study shows that PAF causes goblet cell hyperplasia in airways of guinea pigs and rats. Guinea pigs were sensitive to PAF instillation: A single instillation of PAF resulted in goblet cell hyperplasia, present by 24 h and maximal at approximately 72 h. PAF instillation also resulted in eosinophil recruitment. Pretreatment with NPC 15669, a drug that inhibits leukocyte recruitment (19), prevented PAF-induced eosinophil recruitment but had no effect on PAF-induced goblet cell hyperplasia, suggesting that eosinophil recruitment was not involved in the hyperplasia.
Because guinea pig airways contain goblet cells in the control state, we also studied pathogen-free rats, animals whose airways contain few or no goblet cells. PAF caused a dose- dependent goblet cell development: One or two instillations of PAF produced mostly pregoblet cells; three instillations produced more mature goblet cells. Goblet cell hyperplasia occurred throughout the airways, but the effect was greater in peripheral airways. This could be due to differences in the amount of PAF delivered to various airways, or it could be due to intrinsic differences in responses of the airways at different levels.
Because the enzyme responsible for the breakdown of PAF
(PAF acetylhydrolase) is inhibited by TNF
(16), we examined the effect of TNF
on PAF-induced effects on goblet
cells. When PAF and TNF
were administered together, goblet cell hyperplasia was considerably greater than with PAF
alone. TNF
alone had no effect on goblet cell growth. In addition to TNF
, other inflammatory mediators (e.g., interleukin-1
[IL-1], lipopolysaccharide [LPS]) also inhibit PAF acetylhydrolase (16). Thus, the presence of other inflammatory mediators
could exaggerate effects of PAF and produce pathologic states
of goblet cell hyperplasia.
Mucin genes are believed to be expressed during goblet cell growth (17). MUC5 exists in the airway epithelium (17). Murine overexpression of IL-4 results in goblet cell hyperplasia in airways, which is associated with the expression of MUC5 but not MUC2 (22). In the present studies, instillation of PAF into the airways resulted in expression of MUC5 in cells that stained with Alcian blue/PAS. We suggest that an upregulation of MUC5 messenger RNA (mRNA) and subsequent mucin protein synthesis is responsible, at least in part, for the accumulation of mucus glycoprotein in nonciliated airway epithelial cells after stimulation with PAF.
There is strong evidence that goblet cell hyperplasia and degranulation play major pathophysiologic roles in patients with chronic bronchitis who have airway obstruction (23), in patients dying of acute severe asthma (8), and in cystic fibrosis patients (24). PAF stimulates goblet cell growth and may therefore play a role in the mucous plugging in airways that occurs in these diseases.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Jay A. Nadel, M.D., Box 0130, Cardiovascular Research Institute and Department of Medicine, University of California San Francisco, San Francisco, CA 94143-0130.
(Received in original form September 25, 1997 and in revised form January 6, 1998).
Acknowledgments: The authors thank Dr. Lars Cardell for helpful discussions and Dr. Akira Umeda for technical assistance. They also thank Dr. Carol Basbaum for providing the cDNA for rat MUC5. NPC 15669 was generously provided by Scio Inc., Mountain View, CA.
Supported in part by the Program Project Grant HL-24136 (J.A.N.) and National Research Service Award HL-07185 (Y.-P.L.) from the National Institutes of Health.
| |
References |
|---|
|
|
|---|
1. Venable, M. E., G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. 1993. Platelet-activating factor: a phospholipid autacoid with diverse actions. J. Lipid Res. 34: 691-702 [Medline].
2. Rieves, R. D., J. Goff, T. Wu, P. Larivee, C. Logun, and J. H. Shelhamer. 1992. Airway epithelial cell mucin release: immunologic quantitation and response to platelet-activating factor. Am. J. Respir. Cell Mol. Biol. 6: 158-167 .
3. Hotchkiss, J. A., M. A. Stam, and J. R. Harkema. 1993. Platelet-activating factor stimulates rapid mucin secretion in rat nasal airways in vivo. Exp. Lung Res. 19: 545-557 [Medline].
4. Hsieh, K. H., and C. K. Ng. 1993. Increased plasma platelet-activating factor in children with acute asthmatic attacks and decreased in vivo and in vitro production of platelet-activating factor after immunotherapy. J. Allergy Clin. Immunol. 91: 650-657 [Medline].
5. Tsukioka, K., M. Matsuzaki, M. Nakamata, H. Kayahara, and T. Nakagawa. 1996. Increased plasma level of platelet-activating factor (PAF) and decreased serum PAF acetylhydrolase (PAFAH) activity in adults with bronchial asthma. J. Invest. Allergol. Clin. Immunol. 6: 22-29 [Medline].
6. Miwa, M., T. Miyake, T. Yamanaka, J. Sugatani, Y. Suzuki, S. Sakata, Y. Araki, and M. Matsumoto. 1988. Characterization of serum platelet-activating factor (PAF) acetylhydrolase: correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J. Clin. Invest. 82: 1983-1991 .
7.
Triggiani, M.,
V. De Marino,
M. Sofia,
S. Faraone,
G. Ambrosio,
L. Carratu, and
G. Marone.
1997.
Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage.
Am. J. Respir.
Crit. Care Med.
156:
94-100
8. Saetta, M., A. Di Stefano, C. Rosina, G. Thiene, and L. M. Fabbri. 1991. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am. Rev. Respir. Dis. 143: 138-143 [Medline].
9.
Cardell, B. S., and
R. S. B. Pearson.
1959.
Death in asthmatics.
Thorax
14:
341-352
10. Messer, J. W., G. A. Peters, and W. A. Bennett. 1960. Causes of death and pathological findings in 304 cases of bronchial asthma. Dis. Chest 38: 616-624 .
11. Dunhill, M. S.. 1960. The pathology of asthma with special reference to changes in the bronchial mucosa. J. Clin. Pathol. 13: 27-33 .
12. Houston, J. C., S. De Navasquez, and J. R. Tounce. 1953. A clinical and pathological study of fatal cases of status asthmaticus. Thorax 8: 207-213 .
13. Blyth, D. I., M. S. Pedrick, T. J. Savage, E. M. Hessel, and D. Fattah. 1996. Lung inflammation and epithelial change in a murine model of atopic asthma. Am. J. Respir. Cell Mol. Biol. 14: 425-438 [Abstract].
14.
Henderson, W. R. Jr.,
D. B. Lewis,
R. K. Albert,
Y. Zhang,
W. J. Lamm,
G. K. Chiang,
F. Jones,
P. Eriksen,
Y. T. Tien,
M. Jonas, and
E. Y. Chi.
1996.
The importance of leukotrienes in airway inflammation in a
mouse model of asthma.
J. Exp. Med.
184:
1483-1494
15. Broide, D. H., M. Lotz, J. Cuomo, D. A. Coburn, E. C. Federman, and S. I. Wasserman. 1992. Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89: 958-967 [Medline].
16. Narahara, H., and J. M. Johnston. 1993. Effects of endotoxins and cytokines on the secretion of platelet-activating factor-acetylhydrolase by human decidual macrophages. Am. J. Obstet. Gynecol. 169: 531-537 [Medline].
17. Guzman, K., T. Bader, and P. Nettesheim. 1996. Regulation of MUC5 and MUC1 gene expression: correlation with airway mucous differentiation. Am. J. Physiol. 270 (Lung Cell. Mol. Physiol. 14):L846-L853.
18. Harkema, J. R., and J. A. Hotchkiss. 1992. In vivo effects of endotoxin on intraepithelial mucosubstances in rat pulmonary airways. Am. J. Pathol. 141: 307-317 [Abstract].
19. Noronha-Blob, L., V. C. Lowe, M. Weitzberg, and R. M. Burch. 1991. NPC 15669 enhances survival and reverses leukopenia in endotoxin-treated mice. Eur. J. Pharmacol 199: 387-388 [Medline].
20. Noronha-Blob, L., V. C. Lowe, R. O. Muhlhauser, and R. M. Burch. 1993. NPC 15669, an inhibitor of neutrophil recruitment, is efficacious in acetic acid-induced colitis in rats. Gastroenterology 104: 1021-1029 [Medline].
21. Kaneko, T., P. G. Jorens, J. B. Y. Richman-Eisenstat, P. F. Dazin, and J. A. Nadel. 1994. Leumedin NPC 15669 inhibits antigen-induced recruitment of inflammatory cells into the canine airways. Am. J. Physiol. 267 (Lung Cell. Mol. Physiol. 11):L250-L255.
22. Temann, U.-A., B. Prasad, M. W. Gallup, C. Basbaum, S. B. Ho, R. A. Flavell, and J. Rankin. 1997. A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion. Am. J. Respir. Cell Mol. Biol. 16: 471-478 [Abstract].
23. Thurlbeck, W. M., D. Malaka, and K. Murphy. 1975. Goblet cells in the peripheral airways in chronic bronchitis. Am. Rev. Respir. Dis. 112: 65-69 [Medline].
24. Boat, T. F., and R. C. Boucher. 1994. Cystic fibrosis. In J. F. Murray and J. A. Nadel, editors. Textbook of Respiratory Medicine. W. B. Saunders, Philadelphia. 1418-1450.
This article has been cited by other articles:
![]() |
P-R. Burgel and J. A. Nadel Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases Eur. Respir. J., October 1, 2008; 32(4): 1068 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fukunaga, N. M. Khaskhely, C. S. Sreevidya, S. N. Byrne, and S. E. Ullrich Dermal Dendritic Cells, and Not Langerhans Cells, Play an Essential Role in Inducing an Immune Response J. Immunol., March 1, 2008; 180(5): 3057 - 3064. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. T. Bos, R. Gosens, A. B. Zuidhof, D. Schaafsma, A. J. Halayko, H. Meurs, and J. Zaagsma Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison Eur. Respir. J., October 1, 2007; 30(4): 653 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Kim, S. Y. Lee, S. M. Bak, I. B. Suh, S. Y. Lee, C. Shin, J. J. Shim, K. H. In, K. H. Kang, and S. H. Yoo Effects of matrix metalloproteinase inhibitor on LPS-induced goblet cell metaplasia Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L127 - L133. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Whittaker, N. Niu, U.-A. Temann, A. Stoddard, R. A. Flavell, A. Ray, R. J. Homer, and L. Cohn Interleukin-13 Mediates a Fundamental Pathway for Airway Epithelial Mucus Induced by CD4 T Cells and Interleukin-9 Am. J. Respir. Cell Mol. Biol., November 1, 2002; 27(5): 593 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Wagner, J. A. Hotchkiss, and J. R. Harkema Enhancement of Nasal Inflammatory and Epithelial Responses after Ozone and Allergen Coexposure in Brown Norway Rats Toxicol. Sci., June 1, 2002; 67(2): 284 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-R. Burgel, S. C. Lazarus, D. C.-W. Tam, I. F. Ueki, K. Atabai, M. Birch, and J. A. Nadel Human Eosinophils Induce Mucin Production in Airway Epithelial Cells Via Epidermal Growth Factor Receptor Activation J. Immunol., November 15, 2001; 167(10): 5948 - 5954. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Wagner, S. J. Van Dyken, J. A. Hotchkiss, and J. R. Harkema Endotoxin Enhancement of Ozone-Induced Mucous Cell Metaplasia Is Neutrophil-Dependent in Rat Nasal Epithelium Toxicol. Sci., April 1, 2001; 60(2): 338 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Komori, H. Inoue, K. Matsumoto, H. Koto, S. Fukuyama, H. Aizawa, and N. Hara PAF mediates cigarette smoke-induced goblet cell metaplasia in guinea pig airways Am J Physiol Lung Cell Mol Physiol, March 1, 2001; 280(3): L436 - L441. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. TAKEYAMA, J. V. FAHY, and J. A. NADEL Relationship of Epidermal Growth Factor Receptors to Goblet Cell Production in Human Bronchi Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 511 - 516. [Abstract] [Full Text] |
||||
![]() |
K. Takeyama, B. Jung, J. J. Shim, P.-R. Burgel, T. Dao-Pick, I. F. Ueki, U. Protin, P. Kroschel, and J. A. Nadel Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke Am J Physiol Lung Cell Mol Physiol, January 1, 2001; 280(1): L165 - L172. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Nadel Mechanisms of Airway Hypersecretion and Novel Therapy Chest, May 1, 2000; 117(5_suppl_1): 262S - 266S. [Full Text] [PDF] |
||||
![]() |
H.-M. Lee, K. Takeyama, K. Dabbagh, J. A. Lausier, I. F. Ueki, and J. A. Nadel Agarose plug instillation causes goblet cell metaplasia by activating EGF receptors in rat airways Am J Physiol Lung Cell Mol Physiol, January 1, 2000; 278(1): L185 - L192. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dabbagh, K. Takeyama, H.-M. Lee, I. F. Ueki, J. A. Lausier, and J. A. Nadel IL-4 Induces Mucin Gene Expression and Goblet Cell Metaplasia In Vitro and In Vivo J. Immunol., May 15, 1999; 162(10): 6233 - 6237. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takeyama, K. Dabbagh, H.-M. Lee, C. Agusti, J. A. Lausier, I. F. Ueki, K. M. Grattan, and J. A. Nadel Epidermal growth factor system regulates mucin production in airways PNAS, March 16, 1999; 96(6): 3081 - 3086. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. AGUSTI, K. TAKEYAMA, L. O. CARDELL, I. UEKI, J. LAUSIER, Y.-P. LOU, and J. A. NADEL Goblet Cell Degranulation after Antigen Challenge in Sensitized Guinea Pigs . Role of Neutrophils Am. J. Respir. Crit. Care Med., October 1, 1998; 158(4): 1253 - 1258. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |